TY  - JOUR
TI  - Correction: High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways
AU  - Gerges, Amgad
AU  - Canning, Una
PY  - 2026
JO  - Exploration of Drug Science
VL  - 4
SP  - 1008142
DO  - 10.37349/eds.2026.1008142
UR  - https://www.explorationpub.com/Journals/eds/Article/1008142
ER  -